Protalix BioTherapeutics
PLX
#8648
Rank
A$0.12 B
Marketcap
$1.65
Share price
-4.35%
Change (1 day)
-38.07%
Change (1 year)

Protalix BioTherapeutics (PLX) - Total liabilities

Total liabilities on the balance sheet as of June 2024 : A$94.43 M

According to Protalix BioTherapeutics 's latest financial reports the company's total liabilities are A$94.43 M. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Protalix BioTherapeutics - Total liabilities on balance sheet (from 2001 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31A$74.65 M-23.52%
2022-12-31A$97.61 M-10.95%
2021-12-31A$0.10 B-11.06%
2020-12-31A$0.12 B-25.13%
2019-12-31A$0.16 B1.75%
2018-12-31A$0.16 B24.23%
2017-12-31A$0.13 B1.81%
2016-12-31A$0.12 B7.87%
2015-12-31A$0.11 B-27.41%
2014-12-31A$0.16 B3.87%
2013-12-31A$0.15 B98.65%
2012-12-31A$79.17 M4.23%
2011-12-31A$75.95 M1.12%
2010-12-31A$75.11 M-18.85%
2009-12-31A$92.56 M889.02%
2008-12-31A$9.35 M83.7%
2007-12-31A$5.09 M48.53%
2006-12-31A$3.43 M122.11%
2005-12-31A$1.54 M1583.23%
2004-12-31A$0.09 M-13.48%
2003-12-31A$0.1 M-24.44%
2002-12-31A$0.14 M-7.31%
2001-12-31A$0.15 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
A$0.92 B 879.94%๐Ÿ‡บ๐Ÿ‡ธ USA
A$1.19 B 1,164.00%๐Ÿ‡บ๐Ÿ‡ธ USA
A$192.31 B 203,553.17%๐Ÿ‡บ๐Ÿ‡ธ USA
A$52.15 B 55,134.36%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel